Table 3. SARS-CoV-2 antibody test results of HCWs diagnosed COVID-19 with SARS-CoV-2 PCR.
| Age/sex | Roche Elecsys Anti-SARS-CoV-2 assay | SG Medical R-FIND COVID-19 IgG/M/A ELISA | Abbott Anti-SARS-CoV-2 IgG assay | GenScript cPass SARS-CoV-2 Neutralization Antibody assay | Duration from SARS-CoV-2 PCR confirmation to the antibody test, wks | Profession | Scope of work | Final result of the antibody against SARS-CoV-2a | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Index | Result | OD | Index | Result | Index | Result | Neutralization rate (%) | Result | |||||
| 49/F | 205 | + | 0.650 | 1.83 | + | 5.38 | + | 95.1 | + | 38 | Nurse | Contact with COVID-19 patients | + |
| 61/M | 5.59 | + | 2.126 | 5.45 | + | 10.14 | + | 62.6 | + | 3 | Medical doctor | Contact with COVID-19 patients | + |
| 27/F | 186 | + | 0.256 | 0.73 | − | 3.17 | + | 52.8 | + | 45 | Nurse | Contact with COVID-19 patients | + |
| 27/F | 33.1 | + | 0.311 | 0.89 | − | 1.51 | + | 18.8 | − | 43 | Nurse | Contact with COVID-19 patients | + |
| 32/F | 7.59 | + | 0.081 | 0.22 | − | 0.23 | − | 45.2 | + | 44 | Nurse | Contact with COVID-19 patients | + |
| 38/F | 80.8 | + | 0.184 | 0.51 | − | 0.23 | − | 45.2 | + | 44 | Nurse | Contact with COVID-19 patients | + |
| 49/M | 20.8 | + | 0.289 | 0.88 | − | 0.49 | − | 23.1 | + | 46 | Clerical position | No contact of patients and samples | + |
| 25/F | 79.2 | + | 0.217 | 0.62 | − | 0.96 | − | 19.7 | − | 43 | Nurse | Contact with COVID-19 patients | − |
| 28/M | 24.2 | + | 0.085 | 0.25 | − | 0.37 | − | 19.1 | − | N/A | Clerical position | No contact of patients and samples | − |
| 51/M | 0.31 | − | 0.152 | 0.46 | − | 0.16 | − | −14.4 | − | 45 | Clerical position | Contact with COVID-19 patients | − |
HCW = healthcare worker, COVID-19 = coronavirus disease 2019, SARS-CoV-2 = severe acute respiratory syndrome coronavirus-2, ELISA = enzyme-linked immunosorbent assay, PCR = polymerase chain reaction, N/A = not available, OD = optical density.
aIf 2 or more of the test results were positive, it was determined as positive for the antibody against SARS-CoV-2.